Sign in
4

Changes in Ownership

BIOCRYST PHARMACEUTICALS INC Filed Acc 0001127602-19-033033

Chief Business Officer bought 45,000 shares at $1.45 ($65,250)

From the SEC's structured data for this filing

Trades in this filing

Sniecinski Megan · Chief Business Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2019-11-18 Purchase : show line 1 in the form +45,000 $1.45 $65,250 45,000 D
Open-market purchases · 45,000 sh · avg $1.45 · $65,250
Loading xslF345X03/form4.xml…